AGT and endothelial dysfunction: Our results demonstrated for the first time that dabigatran inhibited the development of endothelial dysfunction detected in vivo by magnetic resonance imaging (MRI), increased systemic NO bioavailability, normalised plasma 20-HETE concentration, and limited endothelial inflammation but did not lower elevated blood pressure and aortic thickening, all of which were induced by Ang II in mice.